Inflammatory reactions and microorganisms cultured from sputum and blood in association with terminal stage infection of patients with lung cancer

T. Rikimaru, Koshi Mimori, M. Ichiki, Y. Ookubo, T. Mitsui, M. Sueyasu, M. Hotta, M. Kinoshita, M. Mastunami, K. Oizumi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

We reviewed our experience with terminal stage infections in patients with lung cancer over an 11 year period at Kurume University Hospital. In patients with end-stage lung cancer, the infection is common and a mortal disease. We examined the clinical features and significance of pathogenic microbes isolated from sputum and blood in patients with lung cancer during their last month. Bacteriological examinations from blood done frequently in patients with episodes of fever revealed that bacteremia was one of the most important disease in terminal stage infection. In the blood cultures from the 22 patients various species of pathogenic microbes were recovered, and nine of which were fungi; five Candida albicans, three Candida tropicalis and one Candida parapsilosis. The major species of bacteria isolated from sputum were Staphylococcus aureus, including methicillin-resistant strain, and Gram-negative bacilli; P. aeruginasa, A. calcoaceticus, K. pneumoniae and E. cloacae, which are known to be frequently involved in hospital-acquired infections. However, S. pneumoniae and H. influenzae which were well known to be microbes of respiratory infections were rare. We concluded that we had to reveal the feature of terminal stage infection in order to reduce the fee for medical treatment and improve the QOL of patients with terminal stage lung cancer.

Original languageEnglish
Pages (from-to)123-127
Number of pages5
JournalKansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases
Volume72
Issue number2
DOIs
Publication statusPublished - Jan 1 1998
Externally publishedYes

Fingerprint

Sputum
Lung Neoplasms
Infection
Pneumonia
Medical Fees
Cloaca
Candida tropicalis
Methicillin-Resistant Staphylococcus aureus
Cross Infection
Bacteremia
Candida albicans
Candida
Respiratory Tract Infections
Bacillus
Human Influenza
Fungi
Fever
Bacteria

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Inflammatory reactions and microorganisms cultured from sputum and blood in association with terminal stage infection of patients with lung cancer. / Rikimaru, T.; Mimori, Koshi; Ichiki, M.; Ookubo, Y.; Mitsui, T.; Sueyasu, M.; Hotta, M.; Kinoshita, M.; Mastunami, M.; Oizumi, K.

In: Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, Vol. 72, No. 2, 01.01.1998, p. 123-127.

Research output: Contribution to journalArticle

Rikimaru, T. ; Mimori, Koshi ; Ichiki, M. ; Ookubo, Y. ; Mitsui, T. ; Sueyasu, M. ; Hotta, M. ; Kinoshita, M. ; Mastunami, M. ; Oizumi, K. / Inflammatory reactions and microorganisms cultured from sputum and blood in association with terminal stage infection of patients with lung cancer. In: Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases. 1998 ; Vol. 72, No. 2. pp. 123-127.
@article{48d788b0fc45472c8aba2786a8553084,
title = "Inflammatory reactions and microorganisms cultured from sputum and blood in association with terminal stage infection of patients with lung cancer",
abstract = "We reviewed our experience with terminal stage infections in patients with lung cancer over an 11 year period at Kurume University Hospital. In patients with end-stage lung cancer, the infection is common and a mortal disease. We examined the clinical features and significance of pathogenic microbes isolated from sputum and blood in patients with lung cancer during their last month. Bacteriological examinations from blood done frequently in patients with episodes of fever revealed that bacteremia was one of the most important disease in terminal stage infection. In the blood cultures from the 22 patients various species of pathogenic microbes were recovered, and nine of which were fungi; five Candida albicans, three Candida tropicalis and one Candida parapsilosis. The major species of bacteria isolated from sputum were Staphylococcus aureus, including methicillin-resistant strain, and Gram-negative bacilli; P. aeruginasa, A. calcoaceticus, K. pneumoniae and E. cloacae, which are known to be frequently involved in hospital-acquired infections. However, S. pneumoniae and H. influenzae which were well known to be microbes of respiratory infections were rare. We concluded that we had to reveal the feature of terminal stage infection in order to reduce the fee for medical treatment and improve the QOL of patients with terminal stage lung cancer.",
author = "T. Rikimaru and Koshi Mimori and M. Ichiki and Y. Ookubo and T. Mitsui and M. Sueyasu and M. Hotta and M. Kinoshita and M. Mastunami and K. Oizumi",
year = "1998",
month = "1",
day = "1",
doi = "10.11150/kansenshogakuzasshi1970.72.123",
language = "English",
volume = "72",
pages = "123--127",
journal = "Nippon Densenbyo Gakkai zasshi",
issn = "0387-5911",
publisher = "Nihon Kansensho Gakkai",
number = "2",

}

TY - JOUR

T1 - Inflammatory reactions and microorganisms cultured from sputum and blood in association with terminal stage infection of patients with lung cancer

AU - Rikimaru, T.

AU - Mimori, Koshi

AU - Ichiki, M.

AU - Ookubo, Y.

AU - Mitsui, T.

AU - Sueyasu, M.

AU - Hotta, M.

AU - Kinoshita, M.

AU - Mastunami, M.

AU - Oizumi, K.

PY - 1998/1/1

Y1 - 1998/1/1

N2 - We reviewed our experience with terminal stage infections in patients with lung cancer over an 11 year period at Kurume University Hospital. In patients with end-stage lung cancer, the infection is common and a mortal disease. We examined the clinical features and significance of pathogenic microbes isolated from sputum and blood in patients with lung cancer during their last month. Bacteriological examinations from blood done frequently in patients with episodes of fever revealed that bacteremia was one of the most important disease in terminal stage infection. In the blood cultures from the 22 patients various species of pathogenic microbes were recovered, and nine of which were fungi; five Candida albicans, three Candida tropicalis and one Candida parapsilosis. The major species of bacteria isolated from sputum were Staphylococcus aureus, including methicillin-resistant strain, and Gram-negative bacilli; P. aeruginasa, A. calcoaceticus, K. pneumoniae and E. cloacae, which are known to be frequently involved in hospital-acquired infections. However, S. pneumoniae and H. influenzae which were well known to be microbes of respiratory infections were rare. We concluded that we had to reveal the feature of terminal stage infection in order to reduce the fee for medical treatment and improve the QOL of patients with terminal stage lung cancer.

AB - We reviewed our experience with terminal stage infections in patients with lung cancer over an 11 year period at Kurume University Hospital. In patients with end-stage lung cancer, the infection is common and a mortal disease. We examined the clinical features and significance of pathogenic microbes isolated from sputum and blood in patients with lung cancer during their last month. Bacteriological examinations from blood done frequently in patients with episodes of fever revealed that bacteremia was one of the most important disease in terminal stage infection. In the blood cultures from the 22 patients various species of pathogenic microbes were recovered, and nine of which were fungi; five Candida albicans, three Candida tropicalis and one Candida parapsilosis. The major species of bacteria isolated from sputum were Staphylococcus aureus, including methicillin-resistant strain, and Gram-negative bacilli; P. aeruginasa, A. calcoaceticus, K. pneumoniae and E. cloacae, which are known to be frequently involved in hospital-acquired infections. However, S. pneumoniae and H. influenzae which were well known to be microbes of respiratory infections were rare. We concluded that we had to reveal the feature of terminal stage infection in order to reduce the fee for medical treatment and improve the QOL of patients with terminal stage lung cancer.

UR - http://www.scopus.com/inward/record.url?scp=0031988978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031988978&partnerID=8YFLogxK

U2 - 10.11150/kansenshogakuzasshi1970.72.123

DO - 10.11150/kansenshogakuzasshi1970.72.123

M3 - Article

VL - 72

SP - 123

EP - 127

JO - Nippon Densenbyo Gakkai zasshi

JF - Nippon Densenbyo Gakkai zasshi

SN - 0387-5911

IS - 2

ER -